Abstract:Aim: To construct the bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor 165 (VEGF-165)genes. Methods: This experiment was conducted at the Common Experimental Flatform of Tongji Medical College, Huazhong University of Science and Technology from March 2005 to October 2005. 1 Through polymerase chain reaction, target gene segment of pcDNA3.1-BMP2 and pUC-CAGGS-VEGF165 were subcloned and new estriction enzyme cutting sites were inducted, then were directionally connected to eukaryotic expression vector pIRES, bicistronic mRNA of two target gene was expressed when constructing. Recombinant plasmid was identified through polymerase chain reaction, enzyme analysis and DNA sequencing. 2 Recombinant plasmid transfected in vitro mouse bone marrow stroma cell induced by liposome. The expression of BMP-2 and VEGF-165 genes was detected through reverse transcriptase-polymerase chain reaction. Results: 1 Construction and id entification of bicistronic eukaryotic expression plasmid pIRES-BMP2-VEGF165: Recombinant plasmid pIRES-BM P2-VEGF165 was treated with Xho I/Mlu I and Xba I /Not I. Electropherosis of 1% agarose showed that there were 1.2 kbp human BMP-2 band and 592 bp vascular endothelial growth factor 165 band enzyme band and the electropherosis band of polymerase chain reaction were placed in the same position. Polymerase chain reaction, enzyme analysis and DNA sequencing proved that the inserting segment direction of target gene was right and no mutation appeared in DNA sequencing. 2 Expression of BMP-2 and VEGF-165 mRNA: transfected pIRES empty plasmid was as negative control, RNA of transfected cells was extracted 48 hours later, then were performed reverse transcriptase-polymerase chain reaction with P1, P2, P3, and P4 as primer. Results demonstrated that mouse bone marrow stroma cell with transfected pIRES-HMP2-VEGF165 amplified 1.2 kbp and 592 bp two bands, which proved that this recombinant plasmid could co-express in vitro bicistronic eukaryotic expression plasmid containing BMP-2 and VEGF-165 mRNA. Conclusion: Bicistronic eukaryotic expression plasmids containing BMP-2 and VEGF-165 mRNA are constructed successfully, which provide the foundation for combination gene therapy in bone defect.

Construction of Recombinant Adenoviral Vector Carrying the Human BMP-2 Gene with the Technology of in Vitro Ligation

Construction and identification of recombinant human bone morphogenetic protein-2 gene adenoviral vector

Construction of Recombinant Adenovirus Vector for Hbmp-2 Gene with Gateway~(TM)Clone Technology

Construction and characterization of an adenoviral vector encoding human bone morphogenetic protein-2.

Construction of a recombinant adenovirus carrying human BMP2 gene and its function of inducing bone formation

Value of construction of bone morphogenetic protein-2 recombinant adenovirus on genetic treatment of bone defect

Construction of Recombinant Adenoviral Vector Encoding Human BMP-2 and Detection of Its Biological Activities

Construction and identification of recombinant adenoviral vector-carrying BMP2

Construction of human BMP7 recombinant adenovirus and its function of inducing bone formation

[Construction and Expression of Recombinant Adenovirus Expression Vector of Beta-Defensin-2].

Construction and in vitro expression of bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 and vascular endothelial growth factor 165 genes

[Construction of Recombinant Adeno-Associated Virus Vector with Human Bone Morphogenetic Protein].

The construction of hbmp7 recombinant adenovirus vector

Construction of recombinant adenovirus carrying rat bone morphogenetic protein-4 by Cre- loxP site-specific recombination

Construction of recombinant adenoviruse vector containing bone human morphogenetic protein-7 and its expression in human periodontal ligament cells

[Construction and Identification of Recombinant Adenoviral Vector Encoding B7-H4 Gene].

Construction of Recombinant Adenovirus Vector Carrying the Human Bone Morphogenetic Protein 12 Gene

Construction and identification of recombinant adenovirus vector with the fusion gene GC2A:GM-SCF and LMP2A

Constructing bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 labeled with green fluorescent protein

Construction of Recombinant Adeno-Associated Virus Vector Co-Expressing Hvegf165 and Hbmp7 Gene

Contruction and Expression of BMP4 Recombinant Adnovirus and Effects on NIH3T3 Fibroblast Cells